Library / Laws / 118th Congress / House Bills / H.R. 1805
H.R. 1805
To mitigate the effects of the COVID–19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2023-03-27 | 4.5K | ⠃⠗⠋ |